How SABIC helped develop a non-drug migraine treatment

SABIC recently helped eNeura develop a clinically proven, non-drug option for preventing and treating migraine headaches.

The sTMS mini from eNeura is a portable delivery system for single-pulse, transcranial magnetic stimulation. It’s prescribed by a physician. FDA cleared the sTMS mini for migraine prevention in 2017.

SABIC’s polycarbonate copolymer Lexan was chosen as the housing of the device. The material is biocompatible, resistance to impact and household chemicals, lightweight for easy handling and can be color matched. SABIC’s injection molder PTA Plastics also contributed to the device.

“Our collaboration with SABIC and PTA Plastics early in the development process helped us accelerate time to market for the sTMS mini migraine device,” said David Rosen, president and CEO of eNeura. “Expert guidance from both companies simplified the process of selecting the best housing material. Fast service from SABIC — including a one-week turnaround on color-matched samples — allowed us to move quickly to prototyping. We’ve had very positive feedback from patients, indicating that Lexan copolymer resin’s performance and attractive aesthetics enhance our device’s usability and overall appeal.”

The Lexan copolymer enhances the usability of the device in different settings, according to the companies. It can withstand everyday use and resists degradation.

Using SABIC’s materials, eNeura developed the device to be easy to use and portable with its compact size. It is designed to be used at home, work or while traveling.

“SABIC innovation is helping to facilitate the home healthcare megatrend, among others,” said Ashir Thakore, global segment leader of healthcare at SABIC. “Our growing portfolio of healthcare grades gives device designers new choices for optimizing portability, ergonomics and comfort – all of which encourage patient compliance. Device OEMs like eNeura are turning to our engineered thermoplastics to meet the specialized requirements of home use.”

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW